Sun Pharmaceutical diclofenac gel recalled for viscosity failure
Sun Pharmaceutical is recalling one lot of Diclofenac Sodium Topical Gel, 3% (Lot #AD92721, expiring 3/31/2027) because the gel's thickness is slightly lower than required specifications. The product was distributed nationwide and is sold by prescription only.
From the FDA notice · Read the official notice ↗ · All Sun Pharmaceutical recalls
What to do
- Check your Diclofenac Sodium Gel 3% tube for Lot #AD92721
- Stop using this lot and do not apply it to your skin
- Contact your pharmacy or doctor for a replacement or alternative pain relief medication
- Do not throw the gel in the trash; ask your pharmacy how to dispose of it safely
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Diclofenac Sodium, Topical Gel, 3%, 100 g tube, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Dist. by Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-1363-7
- Sold in
- Nationwide
- Made for
- Adults (0 months and older)
Details
- Units affected
- N/A
- Illnesses reported
- None reported
- Manufactured in
- 2 Independence Way, N/A, Princeton, NJ, United States
- Classification
- Class II
- Recall number
- D-0342-2026
In the FDA's words
- Description
- Diclofenac Sodium, Topical Gel, 3%, 100 g tube, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Dist. by Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-1363-7 Failed Viscosity Specifications: Out of Specification (OOS) [slightly lower than the limit] result in viscosity for Diclofenac Sodium Gel, 3%. Lot # AD92721, Exp Date: 3/31/2027. Distribution: US Nationwide. Affected quantity: N/A
- Hazard
- Failed Viscosity Specifications: Out of Specification (OOS) [slightly lower than the limit] result in viscosity for Diclofenac Sodium Gel, 3%.
More from Sun Pharmaceutical
See all- Sun Pharmaceutical lisdexamfetamine recalled for failed dissolution
ModerateFDANov 6, 2026
- Taro Tretinoin Cream 0.05% recalled for failed impurity specifications
ModerateFDAOct 14, 2026
- Sun nystatin cream recalled for failed stability specifications
ModerateFDASep 23, 2026
- Sun Pharmaceutical Carbamazepine 200mg tablets recalled for manufacturing defect
ModerateFDAAug 26, 2026